Tracking tumor DNA after prostate removal surgery
Part of Cancer, Kidney & urinary clinical trials.
This study looks at how a marker (tumor DNA) in your drainage fluid changes after prostate removal surgery. It may help predict the outcome of your cancer, giving you more information about your recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have prostate cancer and have had surgery to remove your prostate.
- You cannot have had hormone therapy or chemotherapy before your surgery.
- You should not have urine leakage after surgery (no positive creatinine test of drainage fluid).
- This study involves monitoring tumor DNA in your drainage fluid after surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how PSA levels in drainage fluid change after prostate removal surgery to predict outcomes. It may help doctors understand your recovery and future risk.
This study looks at a simple test on the fluid from your drain after prostate surgery to see if it can help predict how your cancer will progress. If you qualify, your participation may help doctors better monitor patients like you.
This study checks whether a special blood test (ctDNA) taken before and after surgery can predict whether non-small cell lung cancer will come back. If it works, it may help doctors spot recurrence earlier and guide follow-up care after tumor removal.
This trial tests a new way to find microscopic cancer cells (minimal residual disease) in the blood after prostate surgery. If successful, it could help doctors decide if additional treatment is needed.
This study looks for tiny traces of cancer left in the body after treatment and surgery. It may help doctors understand if the cancer could come back, so it can be caught and treated earlier.
This study looks for tiny bits of tumor DNA in your blood after surgery to see if it can help guide future treatment. It's for people who had surgery first (not chemotherapy before surgery) and have not seen the cancer spread.
Hear when a new Prostatic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.